Team:Paris/Notebook/Oligo
From 2008.igem.org
(Difference between revisions)
(→Designed Oligos) |
(→Designed Oligonucleotides) |
||
(9 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
{{Paris/Menu}} | {{Paris/Menu}} | ||
- | + | ||
- | + | ||
- | + | ||
==Designed Oligonucleotides== | ==Designed Oligonucleotides== | ||
{| | {| | ||
Line 107: | Line 105: | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O113 | | style="background: #D4E2EF;" | O113 | ||
- | | FlhDC( | + | | FlhDC(rbs)-R |
| GTTTCTTCCTGCAGCGGCCGCTACTAGTACAGAATAACCAACTTTATTTTTATG | | GTTTCTTCCTGCAGCGGCCGCTACTAGTACAGAATAACCAACTTTATTTTTATG | ||
| 54 | | 54 | ||
| | | | ||
- | | | + | |Amplify the natural rbs of FlhD |
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O114 | | style="background: #D4E2EF;" | O114 | ||
- | | FliA-PCR1-F | + | | xx FliA-PCR1-F |
| GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCCTGATTAACTGAGACTGACGGCAACGC | | GTTTCTTCGAATTCGCGGCCGCTTCTAGAGCCTGATTAACTGAGACTGACGGCAACGC | ||
| 58 | | 58 | ||
Line 121: | Line 119: | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O115 | | style="background: #D4E2EF;" | O115 | ||
- | | FliA-PCR1-R | + | | xx FliA-PCR1-R |
| CAGCCCTGCGTTATATGAGTTATCGGCATGATTATCCGTTTCCGCAGGGTTTTTAATCG | | CAGCCCTGCGTTATATGAGTTATCGGCATGATTATCCGTTTCCGCAGGGTTTTTAATCG | ||
| 59 | | 59 | ||
Line 128: | Line 126: | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O116 | | style="background: #D4E2EF;" | O116 | ||
- | | FliA-PCR2-F | + | | xx FliA-PCR2-F |
| GAAACGGATAATCATGCCGATAACTCATATAACGCAGGGCTG | | GAAACGGATAATCATGCCGATAACTCATATAACGCAGGGCTG | ||
| 42 | | 42 | ||
Line 135: | Line 133: | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O117 | | style="background: #D4E2EF;" | O117 | ||
- | | FliA-PCR2-R | + | | xx FliA-PCR2-R |
| GTTTCTTCCTGCAGCGGCCGCTACTAGTACCATTACACCTTCA | | GTTTCTTCCTGCAGCGGCCGCTACTAGTACCATTACACCTTCA | ||
GCGGTATAGAGTGAACTCACGATAAA | GCGGTATAGAGTGAACTCACGATAAA | ||
Line 185: | Line 183: | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O124 | | style="background: #D4E2EF;" | O124 | ||
- | | | + | | Oligo-pfliL-Forward-TRO |
- | | | + | | TCGAATTCGCGGCCGCTTCTAGAGCAAGGGCGTGTAACAGGCAAC |
- | | | + | | 45 |
- | | | + | | 60°C |
| | | | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O125 | | style="background: #D4E2EF;" | O125 | ||
- | | | + | | Oligo-pfliL-Reverse-TRO |
- | | | + | | TCCTGCAGCGGCCGCTACTAGTAGTCATGTGTTGCGGTCTTCCTGTG |
- | | | + | | 47 |
- | | | + | | 62°C |
| | | | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
Line 206: | Line 204: | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O127 | | style="background: #D4E2EF;" | O127 | ||
- | | | + | | Gene-EnvZ-R-TRO |
- | | | + | | GTTTCTTCCTGCAGCGGCCGCTACTAGTATTATTACCCTTCTTTTGTCGTGCCCTGCGCC |
- | | | + | | 60 |
- | | | + | | 68°C |
| | | | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
Line 220: | Line 218: | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O129 | | style="background: #D4E2EF;" | O129 | ||
- | | | + | | Gene-FlgM-R-TRO |
| GTTTCTTCGAATTCGCGGCCGCTTCTAGTTATTAGTTACTCTGCAAGTCTTGCTGCGCT | | GTTTCTTCGAATTCGCGGCCGCTTCTAGTTATTAGTTACTCTGCAAGTCTTGCTGCGCT | ||
| 59 | | 59 | ||
- | | | + | | 59°C |
| | | | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
Line 234: | Line 232: | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O131 | | style="background: #D4E2EF;" | O131 | ||
- | | | + | | Gene-FlhC-R-TRO |
- | | | + | | GTTTCTTCCTGCAGCGGCCGCTACTAGTATTATTAAACAGCCTGTACTCTCTGTTCATCC |
- | | | + | | 60 |
- | | | + | | 60°C |
| | | | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
Line 248: | Line 246: | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O133 | | style="background: #D4E2EF;" | O133 | ||
- | | | + | | Gene-FlhD-R-TRO |
- | | | + | | GTTTCTTCCTGCAGCGGCCGCTACTAGTATTATTAGGCCCTTTTCTTGCGCAGCGCTTCT |
- | | | + | | 60 |
- | | | + | | 68°C |
| | | | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
Line 262: | Line 260: | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O135 | | style="background: #D4E2EF;" | O135 | ||
- | | xx | + | | xx Gene-FliA-F |
| GTTTCTTCGAATTCGCGGCCGCTTCTAGATGAATTCACTCTATACCGCTGAAG | | GTTTCTTCGAATTCGCGGCCGCTTCTAGATGAATTCACTCTATACCGCTGAAG | ||
| 53 | | 53 | ||
Line 277: | Line 275: | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O137 | | style="background: #D4E2EF;" | O137 | ||
- | | Gene-FliArbs-F | + | | xx Gene-FliArbs-F |
| GTTTCTTCGAATTCGCGGCCGCTTCTAGTAATCATGCCGATAACTCATATAAC | | GTTTCTTCGAATTCGCGGCCGCTTCTAGTAATCATGCCGATAACTCATATAAC | ||
| 53 | | 53 | ||
Line 291: | Line 289: | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
| style="background: #D4E2EF;" | O139 | | style="background: #D4E2EF;" | O139 | ||
- | | | + | | Gene-OmpR-R |
- | | | + | | GTTTCTTCCTGCAGCGGCCGCTACTAGTATTATTATGCTTTAGAGCCGTCCGGTACAAAG |
- | | | + | | 60 |
- | | | + | | 62°C |
| | | | ||
|- style="background: #dddddd;" | |- style="background: #dddddd;" | ||
Line 315: | Line 313: | ||
| GCCTGCAGATGCGTAAAGGAGAAGAACTTTTC | | GCCTGCAGATGCGTAAAGGAGAAGAACTTTTC | ||
| 32 | | 32 | ||
- | |55 | + | | 55 |
- | |Amplify E0240 without the promoter and a PstI restriction site at the beginning | + | | Amplify E0240 without the promoter and a PstI restriction site at the beginning |
+ | |- style="background: #dddddd;" | ||
+ | | style="background: #D4E2EF;" | O143 | ||
+ | | G-PCRmut-1F | ||
+ | | GGCTGTTTATCGTGAACTCACTCTATACCG | ||
+ | | 30 | ||
+ | | 62 | ||
+ | | Mutate the EcoRI site of FliA ( without biobrick prefix) | ||
+ | |- style="background: #dddddd;" | ||
+ | | style="background: #D4E2EF;" | O144 | ||
+ | | P-FliArbs-R | ||
+ | | CTTCCTGCAGCGGCCGCTACTAGTATTAAACAGCCCTGCGTTATATG | ||
+ | | 47 | ||
+ | | 55 - 72 | ||
+ | | Amplify the rbs of FliA | ||
+ | |- style="background: #dddddd;" | ||
+ | | style="background: #D4E2EF;" | O145 | ||
+ | | P-xb-FliA-F | ||
+ | | GCTTCTAGAGCCTGATTAACTGAGACTGAC | ||
+ | | 30 | ||
+ | | 51 - 62 | ||
+ | | No EcoRI site on prefix for amplifying promoter | ||
+ | |- style="background: #dddddd;" | ||
+ | | style="background: #D4E2EF;" | O146 | ||
+ | | P-FliA-R | ||
+ | | GTTTCTTCCTGCAGCGGCCGCTACTAGTATTATATGAGTTATCGGCATGAT | ||
+ | | 51 | ||
+ | | 51 - 71 | ||
+ | | | ||
+ | |- style="background: #dddddd;" | ||
+ | | style="background: #D4E2EF;" | O147 | ||
+ | | G-xb-FliA-F | ||
+ | | CTTCTAGAACGCAGGGCTGTTTATCGTG | ||
+ | | 28 | ||
+ | | 57 - 63 | ||
+ | | Amplify the gene with its natural rbs | ||
+ | |- style="background: #dddddd;" | ||
+ | | style="background: #D4E2EF;" | O148 | ||
+ | | G-mecoFliA-F | ||
+ | | TCGAATTCGCGGCCGCTTCTAGACAGGGCTGTTTATCGTGAACTCACTCTATA | ||
+ | | 53 | ||
+ | | 61 - 74 | ||
+ | | Oligo for second run PCR | ||
+ | |- style="background: #dddddd;" | ||
+ | | style="background: #D4E2EF;" | O149 | ||
+ | | G-spe-FliA-R | ||
+ | | GCTACTAGTATTATTATAACTTACCCAGTTTAGTGCG | ||
+ | | 37 | ||
+ | | 53 - 60 | ||
+ | | Oligo FliA for non-mutated sequence | ||
+ | |- style="background: #dddddd;" | ||
+ | | style="background: #D4E2EF;" | O150 | ||
+ | | G-FliA-R | ||
+ | | TCCTGCAGCGGCCGCTACTAGTATTATTATAACTTACCCAGTTTAGTGCG | ||
+ | | 50 | ||
+ | | 53 - 71 | ||
+ | | Oligo for complete mutated sequence - second run of PCR | ||
+ | |- style="background: #dddddd;" | ||
+ | | style="background: #D4E2EF;" | O151 | ||
+ | | PG-xb-FliA-R | ||
+ | | GCTTCTAGAATTATTATAACTTACCCAGTTTAGTGCG | ||
+ | | 37 | ||
+ | | 53 - 61 | ||
+ | | Oligo reverse with xbaI site for non mutated sequence | ||
+ | |- style="background: #dddddd;" | ||
+ | | style="background: #D4E2EF;" | O152 | ||
+ | | G-PCRmut-2R | ||
+ | | GGGCAGTCGAACTTGCAGGCGCAATGCTTC | ||
+ | | 30 | ||
+ | | 71 | ||
+ | | Oligo for first run of PCR, mutate PstI. | ||
+ | |- style="background: #dddddd;" | ||
+ | | style="background: #D4E2EF;" | O153 | ||
+ | | G-PCRmut-3F | ||
+ | | GAAGCATTGCGCCTGCAAGTTCGACTGCCC | ||
+ | | 30 | ||
+ | | 71 | ||
+ | | Oligo for fisrt run of PCR, mutate PstI. | ||
+ | |- style="background: #dddddd;" | ||
+ | | style="background: #D4E2EF;" | O154 | ||
+ | | pFlhDC-tto-F | ||
+ | | GTTTCTTCGAATTCGCGGCCGCTTCTAGAGGTCGCTGTCGTTCTCAAAATCGGTG | ||
+ | | 55 | ||
+ | | 62 - 75 | ||
+ | | | ||
|} | |} | ||
|}<br style="clear:both" /> | |}<br style="clear:both" /> | ||
<br> | <br> | ||
<br> | <br> |
Latest revision as of 02:50, 27 September 2008
Designed Oligonucleotides
|